Menopause Management - On Demand

About the product

Go to Registration page

ABOUT THIS LEARNING MODULE;

This learning consists of a 2-hour webinar, supplementary readings, a multichoice assessment, discussion points and a reflective template to help you use this education to improve everyday practice.

This learning activity has been accredited by PSNZ Education (Professional Development and Training) for 3 hours of professional learning and is suitable for inclusion in a pharmacist’s records for Continuing Professional Development (CPD) purposes.

Presented by:

Dr Anna Fenton

Anna is a Gynaecological Endocrinologist working at the Canterbury District Health Board (CDHB) and Southern Women’s Health in Christchurch. She has served on the board of Osteoporosis New Zealand and is currently the clinical lead for the CDHB Bone Density Service. Anna is a clinical densitometrist certified by both the ISCD and the ANZBMS. Anna is a member of the PTAC Endocrine Sub-committee. She has special interests in the management of premature ovarian insufficiency and the treatment of women after gynaecological cancer. Anna was co-editor-in-chief of Climacteric, the journal of the International Menopause Society from 2007 until late 2016. She is Immediate Past President of the Australasian Menopause Society. She served on the writing and editorial panel for the most recent IMS Guidelines on women’s midlife health and menopause hormone therapy.

This webinar was recorded in May 2017, reviewed and was updated in 2019 and 2021.

Learning Objectives:

On completion of this course, pharmacists will be able to:

• Describe the physiology of the menopause transition
• Recognise the common symptoms that arise because of oestrogen deficiency
• Recognise the changes that occur in women’s general health at menopause and be able to discuss appropriate health screening assessments
• Explain the variety of evidence-based treatment options available to women at menopause
• Recognise the risks and benefits of menopause hormone therapy in women at menopause
• Identify the mode of action and effects of new therapies for managing menopausal symptoms
• Relevant Competence Standards Assessed: O1.5, O2.2

Go to Registration page